1. Home
  2. ENOV vs EVH Comparison

ENOV vs EVH Comparison

Compare ENOV & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • EVH
  • Stock Information
  • Founded
  • ENOV 1995
  • EVH 2011
  • Country
  • ENOV United States
  • EVH United States
  • Employees
  • ENOV N/A
  • EVH N/A
  • Industry
  • ENOV Fluid Controls
  • EVH Other Consumer Services
  • Sector
  • ENOV Industrials
  • EVH Consumer Discretionary
  • Exchange
  • ENOV Nasdaq
  • EVH Nasdaq
  • Market Cap
  • ENOV 1.7B
  • EVH 1.4B
  • IPO Year
  • ENOV 2008
  • EVH 2015
  • Fundamental
  • Price
  • ENOV $26.48
  • EVH $9.51
  • Analyst Decision
  • ENOV Strong Buy
  • EVH Strong Buy
  • Analyst Count
  • ENOV 5
  • EVH 14
  • Target Price
  • ENOV $55.60
  • EVH $16.93
  • AVG Volume (30 Days)
  • ENOV 1.7M
  • EVH 3.5M
  • Earning Date
  • ENOV 08-07-2025
  • EVH 08-07-2025
  • Dividend Yield
  • ENOV N/A
  • EVH N/A
  • EPS Growth
  • ENOV N/A
  • EVH N/A
  • EPS
  • ENOV N/A
  • EVH N/A
  • Revenue
  • ENOV $2,150,191,000.00
  • EVH $2,398,737,000.00
  • Revenue This Year
  • ENOV $8.23
  • EVH N/A
  • Revenue Next Year
  • ENOV $6.18
  • EVH $16.14
  • P/E Ratio
  • ENOV N/A
  • EVH N/A
  • Revenue Growth
  • ENOV 18.32
  • EVH 10.24
  • 52 Week Low
  • ENOV $26.31
  • EVH $7.06
  • 52 Week High
  • ENOV $49.83
  • EVH $33.63
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 42.48
  • EVH 54.61
  • Support Level
  • ENOV $29.74
  • EVH $11.22
  • Resistance Level
  • ENOV $36.82
  • EVH $11.81
  • Average True Range (ATR)
  • ENOV 1.39
  • EVH 0.48
  • MACD
  • ENOV -0.30
  • EVH -0.11
  • Stochastic Oscillator
  • ENOV 16.77
  • EVH 1.66

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Share on Social Networks: